Flaky zirconium-based metal organic framework material Zr-MOF as well as preparation method and application thereof
By introducing shearing agents into Zr-MOF to block crystal surface growth, efficient and stable sheet-like Zr-MOF was prepared, which solved the problem of low hydrolysis efficiency caused by internality of the active site and achieved the use of organophosphorus toxins. Efficient degradation.
Patent Information
- Application Number
- CN202410944795.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The active sites of existing Zr-MOFs are located inside the crystal, resulting in poor hydrolysis of organophosphorus toxins and that natural enzymes or bacterial catalysts are fragile and difficult to separate in the environment.
By adding shearing agents such as 1,1':3',1"-terbenzene-4,4"-dicarboxylic acid, the growth of the material in the crystal plane is blocked by competing coordination, and a high stability is prepared. The sheet-like Zr-MOF with highly accessible active sites improves the adsorption and degradation of organophosphorus toxins.
It significantly improves the hydrolysis efficiency of Zr-MOF on organophosphorus toxins, provides a more efficient degradation pathway, and has better material stability than biological enzymes, and is suitable for the removal of organophosphorus toxins in the environment.
Smart Images

Figure CN118994612A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of metal organic framework material crystalline material and organic phosphorus toxin degradation, and more specifically relates to a type of sheet zirconium-based metal organic framework material Zr-MOF and a preparation method and application thereof. Background Art
[0002] There is increasing evidence that organophosphate toxins are harmful to human health. For example, triphenyl organophosphate can directly interfere with the functioning of the central nervous system by covalently binding to the active site of acetylcholinesterase, thereby causing severe neurotoxicity. Organophosphate toxins are mostly present in materials as inactive additives, so they can easily be released into our living environment through the food chain enrichment effect. According to the regulations of the US Environmental Protection Agency and the European Chemicals Agency, products containing organophosphate toxins are restricted to use in children's toys and child care products.
[0003] Triphenyl phosphate (TPhP) contains three benzene rings centered on a phosphate bond. It is insoluble in water and difficult to hydrolyze. Currently, the catalysts commonly used in the hydrolysis of TPhP are mostly natural enzymes and bacteria, such as biological enzyme phosphate deesterase and Rhodococcus-Sphingobacterium. However, natural enzymes or bacteria are very fragile in the environment and difficult to separate from complex systems. Metalorganic framework (MOF) is a new type of catalyst with open metal sites and stable structure. In recent years, it has been widely used to simulate the catalytic performance of natural enzymes. Among them, Zr-MOF has strong Lewis acid sites and exhibits catalytic activity similar to phosphohydrolase. However, in the reported Zr-MOF, most of the Lewis acid active sites are located inside the crystal, which limits the substrate accessibility of the active sites, resulting in unsatisfactory hydrolysis efficiency of Zr-MOF for organophosphate toxins. Therefore, the preparation of Zr-MOF materials with both high stability and high catalytic performance, especially those that can fully expose the Lewis acid active sites and accelerate the hydrolysis rate of organophosphorus toxins, is of great significance to human health and social sustainable development and is a challenging problem. Summary of the invention
[0004] The technical problem to be solved by the present invention is to overcome the defects and shortcomings of existing Zr-MOFs, such as active sites being "hidden" inside the crystals and poor substrate accessibility, and to provide a sheet material Zr-MOF having high stability and highly accessible active sites obtained by adding a shearing agent, thereby significantly improving the hydrolysis efficiency of Zr-MOF for organophosphorus toxins.
[0005] Another object of the present invention is to provide the use of the sheet-like Zr-MOF in the degradation of organophosphorus toxins.
[0006] Another object of the present invention is to provide a method for degrading organophosphorus toxins.
[0007] The above-mentioned purpose of the present invention is achieved through the following technical solutions:
[0008] The present invention protects a type of sheet zirconium-based metal organic framework material Zr-MOF. The preparation method of the sheet Zr-MOF comprises the following steps: fully mixing the zirconium salt, organic acid, shearing agent, 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene and polar organic solvent, performing solvent thermal reaction at 100-150° C., reacting completely, and post-processing to obtain the sheet Zr-MOF.
[0009] The high porosity of metal organic frameworks (MOFs) means that most active sites are located inside the crystal. The full exposure of active sites can partially or completely determine the utilization rate and overall performance of MOF-based catalysts. For the first time, the present invention uses zirconium salt as metal salt, 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene as organic ligand, adds structure regulators (i.e., shearing agents) such as 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid, and blocks the growth of the material in the
[001] crystal plane direction through competitive coordination, and finally obtains NU-1000-sheet. NU-1000-sheet has good stability on the basis of retaining the original properties and structure of NU-1000, and significantly improves the adsorption and degradation ability of organophosphorus toxins, providing a new reference pathway for the adsorption and degradation of organophosphorus toxins.
[0010] Preferably, the preparation method of the sheet-like Zr-MOF comprises the following steps: fully mixing the polar organic solvent and part of the organic acid, then adding the zirconium salt and the shearing agent to fully dissolve, heating at 50-150°C, adding 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene and a small amount of organic acid to the heated mixture, fully mixing, and performing a solvent thermal reaction at 100-200°C. After the reaction is complete, post-treatment is performed to obtain the product. NU-1000-sheet can be synthesized by dividing the preparation into two steps or by using a one-pot method to add the required materials at one time. The advantage of preparing NU-1000-sheet in two steps is that adding a part of the organic acid first allows the zirconium salt to remain stable in an acidic environment, and then adding 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene and a small amount of organic acid can obtain a NU-1000-sheet with a better morphology.
[0011] Preferably, the shearing agent is selected from 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid.
[0012] Preferably, the zirconium salt is selected from any one or more of ZrOCl2, ZrCl4, ZrO(NO3)2, ZrO2, and Zr(CO3)2.
[0013] More preferably, the zirconium salt is selected from ZrCl4.
[0014] Preferably, the organic acid is selected from acetic acid or formic acid, more preferably acetic acid.
[0015] Preferably, the polar organic solvent is selected from N,N-dimethylformamide or N,N-dimethylacetamide, more preferably N,N-dimethylformamide.
[0016] Preferably, the molar ratio of the zirconium salt, the shearing agent and 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene is 1:(5-10):(0.1-0.5), more preferably 1:(6-8):(0.2-0.4).
[0017] Preferably, the volume ratio of the acetic acid to the organic solvent is 1:(4-10), more preferably 1:(6-8).
[0018] Preferably, the mixing ratio of the total volume of the polar organic solvent and the organic acid to the total mass of the zirconium salt and 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene is 1:(5-15) mL / mg, more preferably 1:(5-10) mL / mg.
[0019] Furthermore, the preparation of the flaky Zr-MOF also requires the addition of water.
[0020] Furthermore, the volume ratio of water to organic acid is 1:(10-20), more preferably 1:(13-15).
[0021] Preferably, the time required for the reaction to be complete is 0.5 to 1.5 hours.
[0022] Furthermore, the thorough mixing method includes shaking, stirring or ultrasound.
[0023] Furthermore, the post-treatment includes centrifugation, washing, soaking, activation and drying.
[0024] Specifically, the post-treatment operation is as follows: after the reaction is complete, the supernatant is removed, N,N-dimethylformamide or anhydrous methanol is added thereto, crystals on the reaction container are removed by ultrasound, and then a solid product is obtained by centrifugation, the solid product is washed with N,N-dimethylformamide for 1 to 3 times, and then washed with any one of anhydrous methanol, ethanol, acetone or anhydrous acetonitrile for 3 to 5 times, and then immersed in any one of the above solvents (preferably N,N-dimethylformamide), and hydrochloric acid is added to the immersed solution for the last time to activate and wash the material, and finally dried.
[0025] More specifically, the drying step is to vacuum dry for 6 to 48 hours at room temperature and a vacuum degree of 0.001 torr to obtain activated ZrMOF. The purpose of drying is to remove the organic solvent in the ZrMOF framework pores to clear the ZrMOF pores.
[0026] The present invention also protects the use of the sheet-like Zr-MOF in degrading organophosphorus toxins.
[0027] Furthermore, the organophosphorus toxins include one or more of triphenyl organophosphate, disodium p-nitrophenyl phosphate, triethyl phosphate, and glyphosate.
[0028] The present invention also protects a method for degrading organophosphorus toxins, which uses the sheet-like zirconium-based metal organic framework material Zr-MOF to degrade organophosphorus toxins.
[0029] Compared with the prior art, the present invention has the following beneficial effects: for the first time, the present invention uses a shearing agent including 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid as a structural regulator, blocks the growth of the material in the
[001] crystal plane direction through competitive coordination, and obtains a new zirconium-based metal organic framework material NU-1000-sheet. This shearing strategy can make full use of the active sites inside the NU-1000 crystal, thereby significantly improving the hydrolysis ability of organophosphorus toxins, and providing a new reference pathway for the degradation of organophosphorus toxins. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Schematic diagram of the shearing principle and synthesis process of the material obtained in Example 1.
[0031] Figure 2 a is a comparison diagram of the powder X-ray diffraction patterns (PXRD) and simulated PXRD of the materials of Example 1 and Comparative Example 1; Figure 2 b is a comparison of the PXRD and simulated PXRD patterns of the material in comparative example 2.
[0032] Figure 3 a is a scanning (SEM) schematic diagram of the material obtained in Comparative Example 1; Figure 3 b is the SEM of the material obtained in Example 1.
[0033] Figure 4 a is the infrared spectrum of the material obtained in Example 1; Figure 4 b is a statistical diagram of the nitrogen adsorption isotherm and pore size distribution of the material obtained in Example 1 at 77K and 0-1 bar.
[0034] Figure 5a is the SEM of the material obtained in Example 1 immersed in water at room temperature for 48 hours, Figure 5 b is the SEM of the material obtained in Example 1 after being immersed in 90°C water for 48 hours; Figure 5 c is the SEM of the material in Example 1 after being immersed in a strong acid (pH=1) aqueous solution for 24 hours; Figure 5 d is the SEM of the material obtained in Example 1 after being immersed in a strong alkaline (pH=11) aqueous solution for 24 hours; Figure 5 e is the PXRD pattern of the material after treatment under the above conditions.
[0035] Figure 6 a is the UV absorption spectra of the material obtained in Example 1 at three contents; Figure 6 b is the ultraviolet absorption spectra of the material obtained in Comparative Example 1 at three contents; Figure 6 c is a comparison chart of the ultraviolet absorption spectra of the materials obtained in Example 1 and Comparative Example 1 and the blank reagent without adding MOF material; Figure 6 d is the UV fitting result diagram of the materials obtained in Example 1 and Comparative Example 1.
[0036] Figure 7 The figure shows the principle diagram of the hydrolysis of organophosphorus triphenyl ester (a) and the statistical data of the chemical shift of the phosphorus spectrum of the substrate triphenyl phosphate (TPhP) and the product diphenyl phosphate (DPhP) in liquid NMR (b).
[0037] Figure 8 a to c correspond to the nuclear magnetic resonance phosphorus spectra of hydrolyzed triphenyl organic phosphate of the materials obtained in Example 1, Comparative Example 2 and Comparative Example 1, respectively; Figure 8 d is a statistical result diagram of the hydrolysis conversion rates of the materials obtained in Example 1, Comparative Example 1 and Comparative Example 2. DETAILED DESCRIPTION
[0038] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.
[0039] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
[0040] Figure 3 a represents Figure 3 The naming meanings of other figures are similar.
[0041] Example 1 Preparation of NU-1000-sheet
[0042] A method for preparing a flaky Zr-MOF comprises the following steps:
[0043] Take a 20mL glass bottle with a polytetrafluoroethylene gasket, add anhydrous acetic acid (120μL, 98%) and 2mL high-purity N,N-dimethylformamide (DMF, 99.5%), shake well, weigh ZrCl4 (10mg, 0.04mmol) and 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid (90mg, 0.28mmol), add them to the above mixed solution, ultrasonically dissolve and mix evenly, cover the glass bottle tightly and react at 100℃ for 1h. Then take it out and let it stand in the air to cool to room temperature. Subsequently, the organic ligand 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene (10 mg, 0.01 mmol), acetic acid (160 μL, 98%) and 20 μL deionized water were added to the glass bottle cooled to room temperature, and then ultrasonically dissolved and mixed evenly, and the glass bottle was tightly capped and reacted at 120 ° C for 24 hours, then taken out and cooled naturally to room temperature. Finally, all the solution in the bottle was transferred to a centrifuge tube, the supernatant was removed by centrifugation, and the crystals were collected. The washing steps are as follows: wash with DMF 3 times and rinse with anhydrous methanol 3 times. Each washing was soaked in DMF (10 mL, 99.5%) or anhydrous methanol (10 mL, 98%) solvent for 12 hours, and the supernatant was removed by centrifugation (5 minutes, speed of 6000 rpm) between each washing, and then redispersed and washed. After washing, the material was resuspended in DMF (10 mL, 99.5%) and HCl (500 μL, 8M) was added and soaked for 12 hours to activate the material. After activation, the product was collected by centrifugation, washed with anhydrous methanol (10 mL, 98%), and then vacuum dried at room temperature and a vacuum degree of 0.1 torr to obtain a NU-1000-sheet.
[0044] Example 2 Preparation method of NU-1000-sheet
[0045] The difference between Example 2 and Example 1 is that the N,N-dimethylformamide (DMF) is replaced by N,N-dimethylacetamide (DMAC), and the other steps and parameters are the same as those of Example 1.
[0046] Example 3 Preparation method of NU-1000-sheet
[0047] The difference between Example 3 and Example 1 is that the zirconium salt is ZrO(NO3)2, and the other steps, reagents, and parameters are the same as those in Example 1.
[0048] Example 4 Preparation method of NU-1000-sheet
[0049] The difference from Example 1 is that 120 μL of acetic acid is replaced by 120 μL of formic acid, and the other steps, reagents, and parameters are the same as those in Example 1.
[0050] Comparative Example 1 Preparation method of NU-1000
[0051] Take a 20mL glass bottle with a polytetrafluoroethylene gasket on the lid, add 8mL of high-purity N,N-dimethylformamide (DMF, 99.5%) to it, and shake it well. Weigh ZrOCl2·8H2O (96mg, 0.30mmol) and benzoic acid (2.7g, 22.11mmol) and add them to the above mixed solution to dissolve and mix evenly by ultrasonic. Cover the glass bottle tightly and react at 100℃ for 1h, then take it out and cool it to room temperature in air. In the second step, add the organic ligand 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene (40mg, 0.06mmol) to the glass bottle cooled to room temperature, and dissolve and mix evenly by ultrasonic. Cover the glass bottle tightly and react at 120℃ for 48h, then take it out and let it stand in air to cool to room temperature. Finally, transfer all the solution in the bottle to a centrifuge tube, remove the supernatant by centrifugation, and collect the crystals. The washing steps are as follows: wash once with DMF and rinse three times with anhydrous methanol. Soak for 12 hours with DMF (10 mL, 99.5%) or anhydrous methanol (10 mL, 98%) solvent for each washing. Remove the supernatant by centrifugation (5 minutes, speed of 6000 rpm) between each washing, and then re-disperse and wash. The activation steps are as follows: after washing, resuspend the material in DMF (10 mL, 99.5%) and add HCl (500 μL, 8M) to soak for 12 hours to activate the material. After activation, wash with anhydrous methanol (10 mL, 98%) again, and then vacuum dry at room temperature to obtain NU-1000.
[0052] Comparative Example 2MOF-808 and its preparation method
[0053] Take a 20mL glass bottle with a polytetrafluoroethylene gasket on the lid, add 9mL of anhydrous N,N-dimethylformamide (DMF) with a purity of 99.5% and 9mL of anhydrous formic acid with a purity of 98%, and shake well. Weigh benzene trimesic acid (84mg, 0.4mmol) and ZrOCl2·8H2O (258mg, 0.80mmol) and add them to the above mixed solution for ultrasonic dissolution and mixing. Cover the glass bottle tightly and react at 120℃ for 48h, then take it out and cool it to room temperature in the air. Finally, transfer all the solution in the bottle to a centrifuge tube, remove the supernatant by centrifugation, and collect the crystals. The washing steps are as follows: wash once with DMF and rinse 3 times with anhydrous methanol. First, ultrasonically disperse the crystals into DMF (10mL, 99.5%) or anhydrous methanol (10mL, 99%), and then soak for 12h. Remove the supernatant by centrifugation (5 minutes, speed of 6000rpm) between each washing. After washing, the material was resuspended in DMF (10 mL, 99.5%) and HCl (500 μL, 8 M) was added to soak for 12 h to activate the material. After activation, the product was collected by centrifugation, washed with anhydrous methanol (10 mL, 98%), and then dried under vacuum at room temperature to obtain MOF-808.
[0054] Characterization and performance testing of experimental materials
[0055] (1) Microscopic crystal structure
[0056] See the schematic diagram of the microscopic crystal structure of the material prepared in Example 1. Figure 1 . As can be seen from the figure, NU-1000-sheet is a sheet-like framework structure with an approximate hexagonal prism morphology composed of a metal cluster center and an organic linker. The metal cluster is Zr6, and the organic linker is 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene, namely H4TBAPy. The present invention utilizes 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid as a shearing agent to block the growth of the material in the
[001] direction through competitive coordination, and finally obtains NU-1000-sheet.
[0057] PXRD characterization data can be found in Figure 2 a, as can be seen from the figure, the PXRD patterns of NU-1000-sheet obtained in Example 1 and NU-1000 obtained in Comparative Example 1 are in good agreement with their simulated PXRD patterns, proving that they have good crystallinity and are pure phases. The PXRD pattern of MOF-808 in Comparative Example 2 is also in good agreement with its simulated PXRD pattern, also having good crystallinity ( Figure 2 b).
[0058] (2) Determination of material morphology
[0059] In order to observe the morphology information of the materials prepared in Example 1 and Comparative Example 1, the present invention obtained the SEM images of the samples by scanning tunneling microscopy. Figure 3 As shown in a, the material prepared in Comparative Example 1 exhibits a significant hexagonal prism morphology. Figure 3 As shown in b, the NU-1000-sheet prepared in Example 1 is in the shape of a regular hexagonal sheet.
[0060] In addition, the experimental results of Examples 2 to 4 are substantially the same as those of Example 1 and will not be described in detail herein.
[0061] (3) Infrared spectroscopy and aperture measurement
[0062] The infrared spectrum of the obtained sample was measured, and the results were as follows Figure 4 As shown in a, the infrared spectra of Example 1 and Comparative Example 1 obtained by this method show that the stretching vibration peaks of the material before and after shearing remain unchanged, indicating that the present invention does not affect the chemical bonds of the material. In order to test the pore size information of the materials prepared in Example 1 and Comparative Example 1, the samples were subjected to N2 isothermal adsorption tests at 77K nitrogen and 195K. The test results are shown in Figure 4 b. The pore size of NU-1000-sheet prepared in Example 1 is 2.3 nm, and the pore size of NU-1000 prepared in Comparative Example 1 is 2.7 nm, which indicates that the pore characteristics of NU-1000 are well inherited in NU-1000-sheet, and the introduction of shearing agent does not cause much change in the pore information.
[0063] In addition, the experimental results of Examples 2 to 4 are substantially the same as those of Example 1 and will not be described in detail herein.
[0064] (4) Material environmental stability test
[0065] The NU-1000-sheet obtained in Example 1 was placed in an aqueous solution at room temperature and 90°C for 48 hours, and was immersed in an aqueous solution at pH = 1 and pH = 11 for 24 hours at room temperature, and the structural stability of the NU-1000-sheet was studied by SEM and PXRD characterization. After the above treatment, the NU-1000-sheet maintained complete PXRD peaks (such as Figure 5 In addition, from the SEM characterization, the NU-1000-sheet obtained has basically no significant change in morphology after being immersed in various conditions for a period of time, and still maintains the shape of hexagonal nanosheets (as shown in FIG. Figure 5 The overall data proves that the chemical and hydrolytic stability of NU-1000-sheet is much stronger than that of biological enzymes, and has a wide range of application scenarios.
[0066] In addition, the experimental results of Examples 2 to 4 are substantially the same as those of Example 1 and will not be described in detail herein.
[0067] (5) Determination of exposure rate of Lewis acid active sites of materials
[0068] In order to verify that this shearing strategy can fully expose the active sites inside the crystal, the number of Lewis acid active sites in Example 1 and Comparative Example 1 was studied by UV-visible absorption spectroscopy. The basic principle of the determination is as follows: superoxide radicals are generated by riboflavin, and nitro blue tetrazolium chloride (NBT) is used as a detection probe to react with superoxide radicals in a colorimetric manner, showing an obvious absorption peak signal at 626nm. The Lewis acid active sites in Zr-MOF can strongly bind to superoxide radicals, thereby inhibiting the above colorimetric reaction. Figure 6 a is the UV absorption spectra of NU-1000-sheet, riboflavin and NBT prepared in Example 1 with different masses at 500-800nm. The data show that the absorption signal intensity at 626nm is inversely proportional to the mass of the material, which meets the test principle. Figure 6 As shown in b, NU-1000 prepared in Example 1 also showed the same trend. Figure 6 c is the UV absorption spectra of comparative example 1 and example 1 reacting with riboflavin and NBT at the same mass. The results show that the UV maximum absorption peak of NU-1000-sheet is lower than that of NU-1000, indicating that at the same material mass, the material prepared in example 1 has more Lewis acid active sites. After linear fitting of the data, it can be seen that the absorption peak intensity is linearly related to the mass of the material, and the slope of NU-1000-sheet is 2.3 times greater than that of NU-1000 ( Figure 6 d). The overall data demonstrate that the shearing strategy can fully expose the active sites inside the crystal, which is beneficial for the access of organophosphorus toxins.
[0069] (6) Determination of the hydrolysis performance of organophosphorus toxins
[0070] In order to explore the high efficiency of the NU-1000-sheet prepared by the present invention on the hydrolysis performance of organophosphorus toxins, the hydrolysis rate of triphenyl phosphate of the materials obtained in Example 1, Comparative Example 1 and Comparative Example 2 was evaluated by nuclear magnetic resonance phosphorus spectroscopy. Triphenyl phosphate (TPhP) can be decomposed into diphenyl phosphate (DPhP) (such as Figure 7 a), where the chemical shift of TPhP is -17.5 ppm and the chemical shift of DPhP is -10 ppm (as shown in Figure 7b). Three MOFs that replace phosphotrieslipase were introduced into the organophosphorus compound (OPs) hydrolysis system, namely NU-1000 (Comparative Example 1), NU-1000-sheet (Examples 1 to 4), and MOF-808 (Comparative Example 2). Nuclear magnetic resonance phosphorus spectrum analysis showed that all Zr-MOFs prepared in the present invention can play the role of phosphotrieslipase in hydrolyzing TPhP, verifying their phosphotrieslipase-like properties ( Figure 8 In order to quantify the catalytic activity, the peak area of the NMR P spectrum was fitted with first-order kinetics as shown in Figures a to c. Figure 8 As shown in d, the hydrolysis rate of NU-1000-sheet to TPhP is much higher than that of other comparative materials, showing a strong phosphotriesterase-like activity.
[0071] In addition, the MOF materials prepared in Examples 2 to 4 have performance effects substantially similar to those of the MOF material prepared in Example 1.
[0072] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A type of sheet-like zirconium-based metal-organic framework material Zr-MOF, characterized in that: The preparation method of the sheet-like zirconium-based metal organic framework material Zr-MOF comprises the following steps: fully mixing the zirconium salt, organic acid, shearing agent, 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene and polar organic solvent, performing a solvent thermal reaction at 100-150° C., reacting completely, and post-processing to obtain the material.
2. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The shearing agent is selected from 1,1':3',1"-terphenyl-4,4"-dicarboxylic acid.
3. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The zirconium salt is selected from any one or more of ZrOCl2, ZrCl4, ZrO(NO3)2, ZrO2, and Zr(CO3)2.
4. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The organic acid is selected from acetic acid or formic acid.
5. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The polar organic solvent is selected from N,N-dimethylformamide or N,N-dimethylacetamide.
6. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The molar ratio of the zirconium salt, the shearing agent and 1,3,6,8-tetrakis(4-carboxyphenyl)pyrene is 1:(5-10):(0.1-0.5).
7. The sheet-like zirconium-based metal-organic framework material Zr-MOF according to claim 1, characterized in that: The volume ratio of the acetic acid to the polar organic solvent is 1:(4-10).
8. Use of the sheet-like zirconium-based metal organic framework material Zr-MOF according to any one of claims 1 to 7 in the degradation of organophosphorus toxins.
9. The use according to claim 8, characterized in that: The organophosphorus toxins include one or more of triphenyl organophosphate, disodium p-nitrophenyl phosphate, triethyl phosphate, and glyphosate.
10. A method for degrading organophosphorus toxins, characterized in that: Use the sheet-like zirconium-based metal organic framework material Zr-MOF described in any one of claims 1 to 7 to degrade organophosphorus toxins.
Citation Information
Patent Citations
Method for rapidly preparing metal organic layer material and application
CN111804346A
Method for detecting organochlorine pesticide in water body based on MOSS material solid phase microextraction
CN115825273A
Zirconium-based metal organic framework material and application thereof in catalyzing ring-opening copolymerization
CN116284830A
Cited By
Preparation method and application of polymer-metal organic framework doped nanofiber material
CN122707263A
